AboutContactTerms & Privacy
© 2024 Coverager
All Rights Reserved

Antengene Corporation

Developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.

Headquarters
Shanghai, Shanghai, China
Founded
2016
Operating Status
Active
Ownership Type
Business Model
Links
Number of funding rounds 3
Number of investors 11
Total funding amount $238M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.